Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), today announced that preclinical data from the company’s research in dysregulated metabolism will be featured in oral and poster presentations at the 12th International Congress of Inborn Errors of Metabolism (ICIEM), taking place September 3-6, 2013 in Barcelona, Spain.
Help employers find you! Check out all the jobs and post your resume.
